Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches

ConditionsAdvanced or Metastatic Cancer Fear of Cancer Progression Metacognition-based Intervention Supportive-expressive Based Intervention Psychooncology

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorThe University of Hong Kong

About this trial

The present study aims to conduct a randomized controlled trial to assess the effect of CALM intervention and ConquerFear intervention on fear of cancer progression among Chinese patients diagnosed with advanced cancer.

Eligibility criteria

Qualifiers

Cantonese- or Mandarin-speaking Chinese patients recently diagnosed with advanced or metastatic (i.e. stage III or IV) cancer

are the age of 18 years or above

Disqualifiers

Patients with major communication difficulties

are being unwilling or unable to commit 6 psychotherapy sessions

Trial design

Treatments tested in this trial

ConquerFear intervention
CALM intervention
Basic Cancer Care

Treatment groups

261 Participants

are divided into 3 treatment groups

Locations

Queen Mary Hospital-Department of Obstetrics & Gynaecology Hong Kong Hong Kong

Queen Mary Hospital-Department of Oncology Hong Kong Hong Kong

Queen Mary Hospital-Department of Surgery Hong Kong Hong Kong

Tung Wah Hospital-Department of Surgery Hong Kong Hong Kong

Sponsors and collaborators

The University of Hong Kong

Lead sponsor

Research Grants Council, Hong Kong

Collaborator

Source ClinicalTrials.gov